Statin liver safety in non‐alcoholic fatty liver disease: A systematic review and metanalysis

AIMS: Statin liver safety in non‐alcoholic fatty liver disease (NAFLD) patients is not well defined. We analysed differences in liver function tests, including alanine transaminase aminotransferase (ALT), aspartate transaminase (AST) and gamma‐glutamyl transpeptidase (GGT) in NAFLD patients treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Pastori, Daniele, Pani, Arianna, Di Rocco, Arianna, Menichelli, Danilo, Gazzaniga, Gianluca, Farcomeni, Alessio, D'Erasmo, Laura, Angelico, Francesco, Del Ben, Maria, Baratta, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290532/
https://www.ncbi.nlm.nih.gov/pubmed/34133035
http://dx.doi.org/10.1111/bcp.14943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290532/
https://www.ncbi.nlm.nih.gov/pubmed/34133035
http://dx.doi.org/10.1111/bcp.14943

Ejemplares similares